These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 28320106)

  • 1. CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway.
    Cheng C; Yu S; Kong R; Yuan Q; Ma Y; Yang W; Cao G; Xie L
    Biomed Pharmacother; 2017 May; 89():1387-1391. PubMed ID: 28320106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucocalyxin A Attenuates the Activation of Hepatic Stellate Cells Through the TGF-β1/Smad Signaling Pathway.
    Dong Z; Gao Q; Guo H
    DNA Cell Biol; 2018 Mar; 37(3):227-232. PubMed ID: 29327938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scoparone attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway.
    Liu X; Zhao X
    Biomed Pharmacother; 2017 Sep; 93():57-61. PubMed ID: 28623783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
    Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
    J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
    Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
    Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of eIF3a attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
    He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):107-11. PubMed ID: 27262813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
    Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q/tumor necrosis factor-related protein-3 acts as a target treating hepatic fibrosis.
    Sun BR; Li HY; Wang GP; Jia QA; Zhang C
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5374-5382. PubMed ID: 34533812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway.
    Hsieh YC; Lee KC; Lei HJ; Lan KH; Huo TI; Lin YT; Chan CC; Schnabl B; Huang YH; Hou MC; Lin HC
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):813-838. PubMed ID: 34087453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
    J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
    Gong Y; Yang Y
    Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
    Feili X; Wu S; Ye W; Tu J; Lou L
    Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
    Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
    Shang H; Liu X; Guo H
    Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
    Ni XX; Li XY; Wang Q; Hua J
    J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway.
    Fang L; Huang C; Meng X; Wu B; Ma T; Liu X; Zhu Q; Zhan S; Li J
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):335-44. PubMed ID: 25150141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.